These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 33872106)
21. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities. Wood MD; Halfpenny AM; Moore SR Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140 [TBL] [Abstract][Full Text] [Related]
22. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact. Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238 [TBL] [Abstract][Full Text] [Related]
28. Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation. Aboian MS; Solomon DA; Felton E; Mabray MC; Villanueva-Meyer JE; Mueller S; Cha S AJNR Am J Neuroradiol; 2017 Apr; 38(4):795-800. PubMed ID: 28183840 [TBL] [Abstract][Full Text] [Related]
29. Input of molecular analysis in medical management of primary brain tumor patients. Idbaih A; Duran-Peña A; Bonnet C; Ducray F Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669 [TBL] [Abstract][Full Text] [Related]
30. 2021 World Health Organization Classification of Brain Tumors. Meredith DM; Pisapia DJ Continuum (Minneap Minn); 2023 Dec; 29(6):1638-1661. PubMed ID: 38085892 [TBL] [Abstract][Full Text] [Related]
31. H3 K27M-mutant diffuse midline gliomas in different anatomical locations. Wang L; Li Z; Zhang M; Piao Y; Chen L; Liang H; Wei Y; Hu Z; Zhao L; Teng L; Lu D Hum Pathol; 2018 Aug; 78():89-96. PubMed ID: 29727696 [TBL] [Abstract][Full Text] [Related]
32. Circumscribed astrocytic gliomas: Contribution of molecular analyses to histopathology diagnosis in the WHO CNS5 classification. Köy Y; Tihan T Indian J Pathol Microbiol; 2022 May; 65(Supplement):S33-S41. PubMed ID: 35562132 [TBL] [Abstract][Full Text] [Related]
33. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae. Plant-Fox AS; O'Halloran K; Goldman S Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558 [TBL] [Abstract][Full Text] [Related]
34. [Advance of molecular subtyping and precise treatment for gliomas]. Hua W; Mao Y Zhonghua Wai Ke Za Zhi; 2017 Jan; 55(1):63-66. PubMed ID: 28056258 [TBL] [Abstract][Full Text] [Related]
35. A longitudinally extensive H3 K27M-mutant diffuse midline glioma in an elderly patient clinically mimicking central nervous system inflammation: a case report. Babarczy K; Reisz Z; Szabo E; Rajda C; Vecsei L; Bodi I; Klivenyi P; Hortobagyi T; Szalardy L Folia Neuropathol; 2020; 58(4):377-385. PubMed ID: 33480242 [TBL] [Abstract][Full Text] [Related]
36. Diffuse midline glioma-H3K27M mutant. A novel entity with a defining and specific IHC marker. Agarwal P; Aiyer HM Indian J Pathol Microbiol; 2021; 64(2):351-353. PubMed ID: 33851633 [TBL] [Abstract][Full Text] [Related]
37. The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 3-Summary of Imaging Findings on Glioneuronal and Neuronal Tumors. Park YW; Vollmuth P; Foltyn-Dumitru M; Sahm F; Choi KS; Park JE; Ahn SS; Chang JH; Kim SH J Magn Reson Imaging; 2023 Dec; 58(6):1680-1702. PubMed ID: 37715567 [TBL] [Abstract][Full Text] [Related]